Human Metabolome Technologies, Inc. (TYO:6090)
559.00
0.00 (0.00%)
Nov 18, 2026, 9:00 AM JST
TYO:6090 Market Cap
TYO:6090 has a market cap or net worth of 3.03 billion as of November 17, 2026. It is the 37,021st most valuable company in the world and the 3,418th biggest in Japan. Its market cap has decreased by 17.28% in one year.
Market Cap
3.03B
Enterprise Value
2.01B
Revenue
1.48B
Global Rank
Country Rank
#3,418 Japan
PE Ratio
10.54
ChartMarket Cap Chart
Since December 24, 2013, TYO:6090's market cap has decreased from 11.04B to 3.03B, a decrease of -72.56%. That is a compound annual growth rate of -9.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 3.03B | -18.91% |
| Dec 30, 2025 | 3.74B | 2.79% |
| Dec 30, 2024 | 3.63B | -4.00% |
| Dec 29, 2023 | 3.79B | -5.61% |
| Dec 30, 2022 | 4.01B | 5.39% |
| Dec 30, 2021 | 3.81B | -13.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MEDINET | 4.84B |
| Kringle Pharma | 4.67B |
| SUSMED,Inc. | 4.24B |
| PRISM BioLab Co.,LTD | 3.96B |
| Noile-Immune Biotech | 3.73B |
| Chordia Therapeutics | 3.56B |
| Modalis Therapeutics | 3.41B |
| Kohjin Bio | 3.39B |